TB-500 vs BPC-157: Key Differences Explained
A detailed side-by-side comparison of TB-500 and BPC-157 — their origins, mechanisms, tissue affinity, and how they differ in preclinical research.
All articles in Research
A detailed side-by-side comparison of TB-500 and BPC-157 — their origins, mechanisms, tissue affinity, and how they differ in preclinical research.
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes. This overview covers the clinical research behind its metabolic and weight-related effects.
CJC-1295 is a long-acting GHRH analogue that extends the half-life of endogenous growth hormone release. Learn about its mechanism and research findings.
GHK-Cu is a naturally occurring copper-binding tripeptide with broad biological activity. Discover what decades of research have revealed about its skin and tissue repair properties.
Thymosin Alpha-1 is a 28-amino-acid peptide derived from the thymus gland with documented immune-modulatory activity. This article reviews its mechanisms and clinical research history.
PT-141, also known as Bremelanotide, is a melanocortin receptor agonist studied for its central mechanism of action. This review covers the clinical research and pharmacology.
AOD-9604 is a modified fragment of the C-terminus of human growth hormone, developed to isolate the lipolytic properties of HGH without the anabolic or diabetogenic effects.